See the published version of this article at Trials.
This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Learn more about In Review
Study protocol
Hongwei Yuan
Beijing University of Chinese Medicine Affiliated Dongzhimen Hospital
Corresponding Author
ORCiD: https://orcid.org/0000-0002-3017-0479
License:
This work is licensed under a CC BY 4.0 License. Read Full License
View the published article at Trials.
Background: PSCI is a series of syndromes that meet the diagnostic criteria for cognitive impairment that appear after a stroke.The treatment of PSCI with oral drugs alone is not ideal and has obvious side effects. Therefore, complementary and alternative treatments are needed for patients with insufficient or significant side effects of oral medications.Therefore, we will evaluate the clinical effectiveness and safety of acupuncture in the treatment of PSCI.
Methods/design:In this study, patients will be randomly divided into two groups. Intervention group: Acupuncture combined with oral medication. Control group: Western medicine treatment plan.All participants will continue to receive conventional drug treatment. The selection of outcomes will be evaluated by Mini Mental State Examination Scale (MMSE) at week 12.
Discussion:This trial may provide evidence regarding the clinical effectiveness, safety, and cost-effectiveness of acupuncture for patients with PSCI.
Trial registration: Trial registration:ClinicalTrials.gov,ChiCTR2000029926, Registered on 17 February 2020，http://www.chictr.org.cn/showproj.aspx?proj=49356
Keywords
Acupuncture, PSCI, stroke, RCT, Mini Mental State Examination Scale, MMSE
Figure 1
Figure 2
Loading...
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
Peer Review Timeline
CURRENT STATUS: Published
Version 1
Posted 23 Mar, 2020
Published
On 28 Aug, 2020
No community comments so far
Editor assigned
On 26 Mar, 2020
Editorial decision: Revise before peer review
On 26 Mar, 2020
Submission checks complete
On 20 Mar, 2020
First submitted
On 20 Feb, 2020
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Subject Areas
Physical Medicine & Rehab
Learn more about our company.
This preprint is under consideration at Trials. A preprint is a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Learn more about In Review
Study protocol
Hongwei Yuan
Beijing University of Chinese Medicine Affiliated Dongzhimen Hospital
Corresponding Author
ORCiD: https://orcid.org/0000-0002-3017-0479
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
Peer Review Timeline
CURRENT STATUS: Published
Version 1
Posted 23 Mar, 2020
Published
On 28 Aug, 2020
No community comments so far
Editor assigned
On 26 Mar, 2020
Editorial decision: Revise before peer review
On 26 Mar, 2020
Submission checks complete
On 20 Mar, 2020
First submitted
On 20 Feb, 2020
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Subject Areas
Physical Medicine & Rehab
License:
This work is licensed under a CC BY 4.0 License. Read Full License
View the published article at Trials.
Background: PSCI is a series of syndromes that meet the diagnostic criteria for cognitive impairment that appear after a stroke.The treatment of PSCI with oral drugs alone is not ideal and has obvious side effects. Therefore, complementary and alternative treatments are needed for patients with insufficient or significant side effects of oral medications.Therefore, we will evaluate the clinical effectiveness and safety of acupuncture in the treatment of PSCI.
Methods/design:In this study, patients will be randomly divided into two groups. Intervention group: Acupuncture combined with oral medication. Control group: Western medicine treatment plan.All participants will continue to receive conventional drug treatment. The selection of outcomes will be evaluated by Mini Mental State Examination Scale (MMSE) at week 12.
Discussion:This trial may provide evidence regarding the clinical effectiveness, safety, and cost-effectiveness of acupuncture for patients with PSCI.
Trial registration: Trial registration:ClinicalTrials.gov,ChiCTR2000029926, Registered on 17 February 2020，http://www.chictr.org.cn/showproj.aspx?proj=49356
Figure 1
Figure 2
Loading...